Treatt (LON:TET) Trading Down 8.6% – Should You Sell?

Treatt plc (LON:TETGet Free Report)’s share price was down 8.6% during mid-day trading on Wednesday . The stock traded as low as GBX 235 ($3.14) and last traded at GBX 239 ($3.20). Approximately 404,605 shares were traded during trading, a decline of 4% from the average daily volume of 421,295 shares. The stock had previously closed at GBX 261.50 ($3.50).

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on TET. Berenberg Bank lowered their price target on shares of Treatt from GBX 440 to GBX 250 and set a “buy” rating for the company in a research report on Thursday, July 24th. Jefferies Financial Group downgraded shares of Treatt to a “hold” rating and reduced their price objective for the stock from GBX 350 to GBX 260 in a research note on Monday, September 15th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Treatt from GBX 260 to GBX 290 and gave the company a “hold” rating in a research report on Monday, October 6th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of GBX 266.67.

View Our Latest Research Report on Treatt

Treatt Price Performance

The company has a market cap of £138.54 million, a PE ratio of 12.81 and a beta of 1.02. The company has a debt-to-equity ratio of 1.78, a current ratio of 4.06 and a quick ratio of 0.87. The stock’s 50-day moving average is GBX 252.11 and its 200 day moving average is GBX 252.34.

About Treatt

(Get Free Report)

We are a trusted ingredients manufacturer and solutions provider to the global flavour, fragrance and consumer goods markets from our bases in the UK, the US and China. We take pride in developing the ingredient solutions of the future and are supported by a global operational infrastructure that delivers results.

See Also

Receive News & Ratings for Treatt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Treatt and related companies with MarketBeat.com's FREE daily email newsletter.